Ventricular Tachycardia & Ventricular Fibrillation

Introduction

Ventricular tachycardia (VT) is a broad complex (> 120ms) tachycardia ( >110bpm) originating in the ventricles and over riding the normal cardiac conduction.

VT can be sustained or unsustained and monomorphic or polymorphic

  • Sustained = duration > 30 seconds or requiring intervention due to haemodynamic compromise.

  • Non - sustained = Three or more consecutive ventricular complexes terminating spontaneously in < 30 seconds.

  • Monomorphic = QRS morphology is the same for all complexes. It is more common in structural or ischaemic heart disease

  • Polymorphic = VT with continuously varying morphology. More common in electrolyte abnormalities and secondary to drugs.

It requires a huge effort for the heart to remain in persistent VT. When the heart tires it becomes unable to maintain sufficient cardiac output to produce a palpable pulse and a cardiac arrest ensues. This is pulseless VT, which can transform into Ventricular Fibrillation (VF).

Ventricular Fibrillation is characterised by rapid, chaotic, disorganised electrical activity with no identifiable P waves or QRS complexes. The ventricles are quivering rapidly, resulting in ineffective pumping of blood out of the heart. This leads to cardiac arrest, which is fatal if not treated urgently with defibrillation

Ventricular tachycardia - broad complex regular tachycardia.

Ventricular tachycardia - broad complex regular tachycardia.

 
Ventricular Fibrillation - rapid chaotic disorganised electrical activity

Ventricular Fibrillation - rapid chaotic disorganised electrical activity

Risk Factors for VT/VF

  • Increasing age

  • Ischaemic heart disease

  • Structural heart disease

    • LV failure, cardiomyopathy, HOCM

  • Prolonged QT interval

    • electrolytes - hypomagnesaemia, hypocalcaemia

    • drugs - TCA’s, quinolones, older antipsychotics,

  • FHx of sudden cardiac death

Clinical Features

 

Symptoms

Systemic

  • Fatigue, impending sense of doom, pre-syncope

Cardiovascular

  • chest pain, palpitations, diaphoresis,

Respiratory

  • SOB, cough productive of pink frothy sputum.

Signs

Signs of shock

  • Tachycardia, hypotension, pallor, hypoxia, delayed CRT,

Signs of heart failure

  • Tachypnoea, bilateral crackles, gallop rhythm, raised JVP, peripheral oedema

 

Differential Diagnosis

 

Broad Complex Tachy-arrhythmia

HR > 100 + Regular Broad Complex

  • Ventricular Tachycardia (VT) - rate > 110bpm

  • Sinus tachycardia with aberrancy

  • SVT with aberrancy

  • Accelerated intra-ventricular rhythm - HR 40–110

HR > 100 + Irregular Broad Complex

  • Polymorphic VT i.e. Torsades de Pointes

  • AF with aberrancy

  • AF with WPW

 

Clinical Investigations

 

Ventricular Tachycardia (with or without a pulse) and Ventricular Fibrillation are life threatening cardiac emergencies and are common causes of cardiac arrest and death if not treated urgently.

A rhythm strip on a defibrillator +/- an ECG are sufficient to make the diagnosis. No further investigations are necessary and treatment should not be delayed.

Once a safe perfusing rhythm has been restored, investigations should be performed to ascertain the cause of the VT/VF and to outrule any complications resulting from same.

 
Picture1.jpg

Bedside

ECG

  • Ventricular tachycardia

    • Rate > 110bpm. QRS > 160 ms

    • Concordance of V1 - V6 (all QRS complexes pointing same direction)

    • Absence of typical LBBB/RBBB morphology

    • May see AV dissociation, Capture beats, Fusion beats

  • Post cardioversion

    • look for signs of ischaemia

    • look for evidence of conduction abnormality e.g. Brugada syndrome

    • assess for presence of prolonged QT interval - common cause of polymorphic VT

VBG

  • Poorly perfusing rhythm —> High lactate, low pH

  • Assess for Hypokolaemia

blood%2Bbottles.jpg

Laboratory

FBC, CRP

  • elevated acute phase reactants

Troponin

  • elevated troponin can occur secondary to primary ischaemic event causing the arrhythmia, or may be as a result of rate related troponin leak or secondary to CPR/Cardioversion

Magnesium, Calcium, Potassium

  • low Ca2+, low K+, low Mg2+ can all cause prolong QT interval

Screenshot+2020-11-03+at+11.10.33.jpg

Radiology

Trans thoracic echo

  • ? regional wall motion abnormality, ? cardiomyopathy

CXR

  • signs of heart failure

CT Brain

  • if prolonged cardiac arrest ? hypoxic brain injury.

Coronary angiogram

  • urgent PCI if STEMI on post cardioversion ECG

 

Management and Disposition

 

Initial Resuscitation

VT is a life threatening time critical emergency with the potential to deteriorate to VF and cardiac arrest. In the immediate setting there are 2 questions you need to ask yourself.

  1. Does the patient have a pulse?

  2. If they do have a pulse are they stable or unstable?

Screenshot 2021-01-11 at 16.18.00.png

Pulseless VT/VF

  • Call for help

  • Commence CPR

  • Task someone to manage the airway. Apply O2

  • Attach defib/AED as soon as possible

    • VT + VF are shockable rhythms

    • if patient is on the defib and VT/VF arrest is witnessed shock them immediately otherwise analyse the rhythm and shock if inidcated as soon as the defib is available

    • Early defibrillation is recognised as a priority in the chain of survival. The likelihood of success decreases with time until initiation

  • Follow the shockable rhythm ACLS cardiac arrest algorithm opposite.

    (courtesy of https://www.aclsmedicaltraining.com/adult-cardiac-arrest-vtach-and-vfib/)

 
Attachment-1%5B2%5D.jpg

Unstable VT

  • Should be managed in resus with full non invasive monitoring

  • Instability is implied if the patient is hypotensive, has a decreased level of consciousness, has signs of heart failure or chest pain.

  • Call for help

  • Task someone to manage the airway. Apply O2

  • Establish IV access

  • Synchronised DC cardioversion with 100J in the first instance.

Screenshot+2021-01-11+at+16.55.09.jpg

Stable VT

  • Should be managed in resus with full non invasive monitoring.

  • Stability is implied if the patient is awake and alert with a perfusing blood pressure. The stable patient with VT is at high risk of becoming unstable and suffering a cardiac arrest.

  • Initial treatment involves loading with antiarrhythmic

    • IV amiodarone 150mg over 10 mins. Can be repeated x 1. Then commence amiodarone infusion

    • IV lignocaine or Sotalol are alternatives

    • Replace electrolytes if Torsades de Pointes/Polymorphic VT

      • IV MgSO4, IV KCl, IV Calcium as indicated

  • If patient becomes unstable at any time proceed to urgent synchronised DC cardioversion

Specific Treatment

  • Once sinus rhythm is restored seek and treat underlying cause

    • e.g. ischaemia, structural heart disease, electrolytes, drugs

  • Post cardiac arrest care

    • optimise airway, respiratory and haemodynamic parameters

Disposition

  • If evidence of acute ischaemic cause (i.e. STEMI) urgent transfer to cath lab for primary PCI

  • If conscious = Admission to a high acuity monitored area (e.g. CCU/HDU) under Cardiology service for further work up and ongoing management.

  • Unconscious patients requiring advanced airway management +/- other organ support will need to be admitted to ICU for ongoing care

 

References.

  1. Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

  2. Dunn. R. Cardiac arrhythmias. The emergency medicine manual 5th edition. Vol 1.

This blog was written by Dr Gillian Cotter and was last updated in January 2021

 Before you go have another look at the clinical case and see have your answers to any of the questions changed and if so how?